Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Value of HPV testing in follow-up of treated high-risk CIN1: a study by Alonso et al.

Thaker P, Kizer NT, Nguyen T, Zighelboim I, Allsworth J.

Am J Obstet Gynecol. 2007 Oct;197(4):433-4; discussion e1-4. No abstract available.

PMID:
17904992
2.

Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol.

Crum CP, Beach KJ, Hedley ML, Yuan L, Lee KR, Wright TC, Urban RG.

J Infect Dis. 2004 Apr 15;189(8):1348-54. Epub 2004 Mar 30.

PMID:
15073670
3.

HPV testing in the follow-up after treatment of women with CIN.

von Keyserling H, Kaufmann AM, Schneider A.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S5-7. Epub 2007 Aug 31. No abstract available.

PMID:
17764728
4.
5.

HPV DNA testing in cervical cancer screening: from evidence to policies.

Cox T, Cuzick J.

Gynecol Oncol. 2006 Oct;103(1):8-11. Epub 2006 Aug 21. No abstract available.

PMID:
16919716
6.

HPV testing for cervical neoplasia.

Carozzi F, Confortini M, Cecchini S, Ciatto S.

Acta Cytol. 2001 Jul-Aug;45(4):659-61. No abstract available.

PMID:
11480738
7.
8.

Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions.

Cabibi D, Giovannelli L, Martorana A, Migliore MC, Tripodo C, Campione M, Ammatuna P, Aragona F.

Histopathology. 2007 Nov;51(5):713-6. No abstract available.

PMID:
17927598
9.

Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.

Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Erzen M, Sarian LO, Juschenko A, Costa S, Podistov J, Syrjänen S; New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups..

Int J Gynecol Cancer. 2009 Jul;19(5):934-42. doi: 10.1111/IGC.0b013e3181a834fe.

PMID:
19574788
10.

The expression of p16 is not correlated with HPV status in CINI.

Galmiche L, Coste-Burel M, Lopes P, Phillippe HJ, Laboisse C.

Histopathology. 2006 May;48(6):767. No abstract available.

PMID:
16681697
11.

Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.

Spinillo A, Dal Bello B, Gardella B, Roccio M, Dacco' MD, Silini EM.

Gynecol Oncol. 2009 Apr;113(1):115-9. doi: 10.1016/j.ygyno.2008.12.037. Epub 2009 Jan 31.

PMID:
19181368
12.

Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.

Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N.

J Clin Microbiol. 2008 Jan;46(1):274-80. Epub 2007 Oct 31.

13.

HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.

De Marchi Triglia R, Metze K, Zeferino LC, Lucci De Angelo Andrade LA.

Gynecol Oncol. 2009 Jan;112(1):114-8. doi: 10.1016/j.ygyno.2008.09.047. Epub 2008 Nov 12.

PMID:
19007972
14.

Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions.

Bello BD, Spinillo A, Alberizzi P, Cesari S, Gardella B, D'Ambrosio G, Roccio M, Silini EM.

J Med Virol. 2009 Apr;81(4):703-12. doi: 10.1002/jmv.21429.

PMID:
19235847
15.

HR-HPV DNA to differentiate between cervical pemphigus and CIN: a case report.

Karanjgaokar V, Khan A, Ramachandra S, Pisal N.

Arch Gynecol Obstet. 2008 Apr;277(4):349-51. Epub 2007 Sep 29. No abstract available.

PMID:
17906869
16.

Use of human papillomavirus testing in the management of atypical glandular cells.

Schnatz PF, Sharpless KE, O'Sullivan DM.

J Low Genit Tract Dis. 2009 Apr;13(2):94-101. doi: 10.1097/LGT.0b013e318183a438.

PMID:
19387129
17.

Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.

Fallani MG, Penna C, Marchionni M, Bussani C, Pieralli A, Andersson KL, Fambrini M.

Eur J Gynaecol Oncol. 2008;29(4):378-82.

PMID:
18714574
18.

Natural history of persistent high-risk human papillomavirus infections in Korean women.

Bae J, Seo SS, Park YS, Dong SM, Kang S, Myung SK, Park SY.

Gynecol Oncol. 2009 Oct;115(1):75-80. doi: 10.1016/j.ygyno.2009.06.016. Epub 2009 Jul 19.

PMID:
19619893
19.

Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes.

Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M.

J Med Virol. 2009 Feb;81(2):271-7. doi: 10.1002/jmv.21382.

PMID:
19107962
20.

Appendix to: "PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO(2) conization for high-grade cervical intraepithelial neoplasia".

Pieralli A, Bussani C, Andersson KL, Mattei A, Fambrini M.

Gynecol Oncol. 2010 Mar;116(3):586-7. doi: 10.1016/j.ygyno.2009.11.010. Epub 2009 Dec 6. No abstract available.

PMID:
19969337

Supplemental Content

Support Center